Stephen Marks
Impact in
- Toxicology top 5%
- Forensic Toxicology and Drug Analysis
- Parasitology top 10%
- Vector-borne infectious diseases
Papers in ⓘ
-
- Forensic Toxicology and Drug Analysis 2
-
- Venous Thromboembolism Diagnosis and Management 2
- Co-authors
- Alan J. Tuchman (2 shared papers)Michael Daras (2 shared papers)Jesse Weinberger (2 shared papers)Stephen J. Dumler (1 shared paper)Harold W. Horowitz (1 shared paper)Michael Weintraub (1 shared paper)Thomas A. Lansen (1 shared paper)William H. Frishman (2 shared papers)
- Journals
- Neurology (2 papers)Stroke (2 papers)Gastroenterology (1 paper)Transplant International (1 paper)Parasitology Research (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Stephen Marks
19 papers receiving 305 citations
Peers
Comparison fields: 5 of 64
- Toxicology 35
- Parasitology 32
- Neurology 60
- Internal Medicine 11
- Pulmonary and Respiratory Medicine 88
Countries citing papers authored by Stephen Marks
This map shows the geographic impact of Stephen Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Marks more than expected).
Fields of papers citing papers by Stephen Marks
This network shows the impact of papers produced by Stephen Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Marks. The network helps show where Stephen Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 66 | |
| 2 | 1990 | 40 | |
| 3 | 1996 | 35 | |
| 4 | 1986 | 25 | |
| 5 | 1999 | 23 | |
| 6 | 2010 | 20 | |
| 7 | 1987 | 19 | |
| 8 | 1993 | 16 | |
| 9 | 1997 | 15 | |
| 10 | 2017 | 13 | |
| 11 | 2013 | 13 | |
| 12 | 1992 | 7 | |
| 13 | 2015 | 6 | |
| 14 | 2002 | 6 | |
| 15 | 1977 | 4 | |
| 16 | LONG-TERM OUTCOME OF HLA-ANTIBODY AND ABO INCOMPATIBLE KIDNEY TRANSPLANTATION | 2013 | 3 |
| 17 | Hemorrhagic Transformation of Ischemic Stroke in Patient Treated With Rivaroxaban | 2013 | 2 |
| 18 | 1991 | 2 | |
| 19 | 2014 | 1 |
About Stephen Marks
Stephen Marks is a scholar working on Toxicology, Internal Medicine, Transplantation, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 316 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Cardiovascular and Diving-Related Complications (3 papers), Opioid Use Disorder Treatment (2 papers), Forensic Toxicology and Drug Analysis (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Toxicology (35 citations), Parasitology (32 citations), Neurology (60 citations), Internal Medicine (11 citations) and Pulmonary and Respiratory Medicine (88 citations). Stephen Marks has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Alan J. Tuchman, Michael Daras, Jesse Weinberger, Stephen J. Dumler, Harold W. Horowitz, Michael Weintraub, Thomas A. Lansen, William H. Frishman, Marcelo E. Lancman and Harshad Amin. Their work appears in journals such as Neurology, Stroke, Gastroenterology, Transplant International and Parasitology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.